374 related articles for article (PubMed ID: 23216165)
1. Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers.
Kim MS; Je EM; Oh JE; Yoo NJ; Lee SH
APMIS; 2013 Jul; 121(7):626-33. PubMed ID: 23216165
[TBL] [Abstract][Full Text] [Related]
2. Mutational and expressional analysis of SMC2 gene in gastric and colorectal cancers with microsatellite instability.
Je EM; Yoo NJ; Lee SH
APMIS; 2014 Jun; 122(6):499-504. PubMed ID: 24483990
[TBL] [Abstract][Full Text] [Related]
3. Mutational and expressional analyses of ATG5, an autophagy-related gene, in gastrointestinal cancers.
An CH; Kim MS; Yoo NJ; Park SW; Lee SH
Pathol Res Pract; 2011 Jul; 207(7):433-7. PubMed ID: 21664058
[TBL] [Abstract][Full Text] [Related]
4. Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer.
García-Flores M; Casanova-Salas I; Rubio-Briones J; Calatrava A; Domínguez-Escrig J; Rubio L; Ramírez-Backhaus M; Fernández-Serra A; García-Casado Z; López-Guerrero JA
Eur J Cancer; 2014 Nov; 50(17):2994-3002. PubMed ID: 25204806
[TBL] [Abstract][Full Text] [Related]
5. Somatic frameshift mutations of bone morphogenic protein receptor 2 gene in gastric and colorectal cancers with microsatellite instability.
Park SW; Hur SY; Yoo NJ; Lee SH
APMIS; 2010 Nov; 118(11):824-9. PubMed ID: 20955454
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations of caspase-2 gene in gastric and colorectal cancers.
Kim MS; Kim HS; Jeong EG; Soung YH; Yoo NJ; Lee SH
Pathol Res Pract; 2011 Oct; 207(10):640-4. PubMed ID: 21940110
[TBL] [Abstract][Full Text] [Related]
7. Frameshift mutations of MUC15 gene in gastric and its regional heterogeneity in gastric and colorectal cancers.
Oh HR; An CH; Yoo NJ; Lee SH
Pathol Oncol Res; 2015 Jul; 21(3):713-8. PubMed ID: 25573589
[TBL] [Abstract][Full Text] [Related]
8. Destruction of DDIT3/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants.
Zhang P; Gao K; Tang Y; Jin X; An J; Yu H; Wang H; Zhang Y; Wang D; Huang H; Yu L; Wang C
Hum Mutat; 2014 Sep; 35(9):1142-51. PubMed ID: 24990631
[TBL] [Abstract][Full Text] [Related]
9. Frameshift mutations of axon guidance genes ROBO1 and ROBO2 in gastric and colorectal cancers with microsatellite instability.
Je EM; Gwak M; Oh H; Choi MR; Choi YJ; Lee SH; Yoo NJ
Pathology; 2013 Dec; 45(7):645-50. PubMed ID: 24247621
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas.
Lee JW; Kim MR; Soung YH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
APMIS; 2006 Sep; 114(9):646-50. PubMed ID: 16948818
[TBL] [Abstract][Full Text] [Related]
11. Mutational and expressional analyses of STAG2 gene in solid cancers.
Kim MS; Kim SS; Je EM; Yoo NJ; Lee SH
Neoplasma; 2012; 59(5):524-9. PubMed ID: 22668012
[TBL] [Abstract][Full Text] [Related]
12. Mutational and expressional analysis of RFC3, a clamp loader in DNA replication, in gastric and colorectal cancers.
Kim YR; Song SY; Kim SS; An CH; Lee SH; Yoo NJ
Hum Pathol; 2010 Oct; 41(10):1431-7. PubMed ID: 20573375
[TBL] [Abstract][Full Text] [Related]
13. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
[TBL] [Abstract][Full Text] [Related]
14. Frameshift mutations of tumor suppressor gene EP300 in gastric and colorectal cancers with high microsatellite instability.
Kim MS; Lee SH; Yoo NJ; Lee SH
Hum Pathol; 2013 Oct; 44(10):2064-70. PubMed ID: 23759652
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias.
Yoo NJ; Park SW; Lee SH
Pathology; 2012 Jan; 44(1):29-32. PubMed ID: 22081132
[TBL] [Abstract][Full Text] [Related]
16. Expressional and mutational analysis of ATRX gene in gastric, colorectal and prostate cancers.
Je EM; An CH; Yoo NJ; Lee SH
APMIS; 2012 Jun; 120(6):519-20. PubMed ID: 22583365
[No Abstract] [Full Text] [Related]
17. Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer.
Jin X; Wang J; Gao K; Zhang P; Yao L; Tang Y; Tang L; Ma J; Xiao J; Zhang E; Zhu J; Zhang B; Zhao SM; Li Y; Ren S; Huang H; Yu L; Wang C
PLoS Genet; 2017 Apr; 13(4):e1006748. PubMed ID: 28448495
[TBL] [Abstract][Full Text] [Related]
18. Speckle-type POZ protein suppresses lipid accumulation and prostate cancer growth by stabilizing fatty acid synthase.
Gang X; Xuan L; Zhao X; Lv Y; Li F; Wang Y; Wang G
Prostate; 2019 Jun; 79(8):864-871. PubMed ID: 30955223
[TBL] [Abstract][Full Text] [Related]
19. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
